Literature DB >> 25448805

Toxicity assessment of aggregated/agglomerated cerium oxide nanoparticles in an in vitro 3D airway model: the influence of mucociliary clearance.

C Frieke Kuper1, Mariska Gröllers-Mulderij2, Thérèse Maarschalkerweerd3, Nicole M M Meulendijks4, Astrid Reus5, Frédérique van Acker6, Esther K Zondervan-van den Beuken7, Mariëlle E L Wouters8, Sabina Bijlsma9, Ingeborg M Kooter10.   

Abstract

We investigated the toxicity of aggregated nanoparticles of cerium oxide (CeO2) using an in vitro 3D human bronchial epithelial model that included a mucociliary apparatus (MucilAir™). CeO2 was dispersed in saline and applied to the apical surface of the model. CeO2 did not induce distinct effects in the model, whereas it did in BEAS-2B and A549 cell cultures. The absence of effects of CeO2 was not because of the model's insensitivity. Nanoparticles of zinc oxide (ZnO) elicited positive responses in the toxicological assays. Respiratory mucus (0.1% and 1%) added to dispersions increased aggregation/agglomeration to such an extent that most CeO2 sedimented within a few minutes. Also, the mucociliary apparatus of the model removed CeO2 from the central part of the apical surface to the borders. This 'clearance' may have prevented the majority of CeO2 from reaching the epithelial cells. Chemical analysis of cerium in the basal tissue culture medium showed only minimal translocation of cerium across the 3D barrier. In conclusion, mucociliary defence appeared to prevent CeO2 reaching the respiratory epithelial cells in this 3D in vitro model. This model and approach can be used to study compounds of specific toxicological concern in airway defence mechanisms in vitro.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cerium oxide; In vitro 3D human bronchial epithelial model; Mucociliary apparatus; Mucociliary clearance

Mesh:

Substances:

Year:  2014        PMID: 25448805     DOI: 10.1016/j.tiv.2014.10.017

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  14 in total

1.  3D Tumor Spheroid Models for In Vitro Therapeutic Screening of Nanoparticles.

Authors:  Simonas Daunys; Agnė Janonienė; Indrė Januškevičienė; Miglė Paškevičiūtė; Vilma Petrikaitė
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  The impact of nanomaterial characteristics on inhalation toxicity.

Authors:  Frank S Bierkandt; Lars Leibrock; Sandra Wagener; Peter Laux; Andreas Luch
Journal:  Toxicol Res (Camb)       Date:  2018-02-01       Impact factor: 3.524

Review 3.  Cells and Culture Systems Used to Model the Small Airway Epithelium.

Authors:  Rudra Bhowmick; Heather Gappa-Fahlenkamp
Journal:  Lung       Date:  2016-04-12       Impact factor: 2.584

4.  Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy.

Authors:  Panagiotis Mastorakos; Adriana L da Silva; Jane Chisholm; Eric Song; Won Kyu Choi; Michael P Boyle; Marcelo M Morales; Justin Hanes; Jung Soo Suk
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-29       Impact factor: 11.205

5.  Hazard Assessment of Benchmark Metal-Based Nanomaterials Through a Set of In Vitro Genotoxicity Assays.

Authors:  Maria Dušinská; Maria João Silva; Nádia Vital; Mariana Pinhão; Naouale El Yamani; Elise Rundén-Pran; Henriqueta Louro
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

6.  Multiparametric investigation of non functionalized-AGuIX nanoparticles in 3D human airway epithelium models demonstrates preferential targeting of tumor cells.

Authors:  Lucie Sancey; Odile Sabido; Zhiguo He; Fabien Rossetti; Alain Guignandon; Valérie Bin; Jean-Luc Coll; Michèle Cottier; François Lux; Olivier Tillement; Samuel Constant; Christophe Mas; Delphine Boudard
Journal:  J Nanobiotechnology       Date:  2020-09-10       Impact factor: 10.435

Review 7.  Progress and future of in vitro models to study translocation of nanoparticles.

Authors:  Hedwig M Braakhuis; Samantha K Kloet; Sanja Kezic; Frieke Kuper; Margriet V D Z Park; Susann Bellmann; Meike van der Zande; Séverine Le Gac; Petra Krystek; Ruud J B Peters; Ivonne M C M Rietjens; Hans Bouwmeester
Journal:  Arch Toxicol       Date:  2015-05-15       Impact factor: 5.153

Review 8.  Mechanistic insight into the impact of nanomaterials on asthma and allergic airway disease.

Authors:  Kirsty Meldrum; Chang Guo; Emma L Marczylo; Timothy W Gant; Rachel Smith; Martin O Leonard
Journal:  Part Fibre Toxicol       Date:  2017-11-21       Impact factor: 9.400

9.  Molecular Signature of Asthma-Enhanced Sensitivity to CuO Nanoparticle Aerosols from 3D Cell Model.

Authors:  Ingeborg Kooter; Marit Ilves; Mariska Gröllers-Mulderij; Evert Duistermaat; Peter C Tromp; Frieke Kuper; Pia Kinaret; Kai Savolainen; Dario Greco; Piia Karisola; Joseph Ndika; Harri Alenius
Journal:  ACS Nano       Date:  2019-06-17       Impact factor: 15.881

10.  Nanoparticle induced barrier function assessment at liquid-liquid and air-liquid interface in novel human lung epithelia cell lines.

Authors:  Lars Leibrock; Sandra Wagener; Ajay Vikram Singh; Peter Laux; Andreas Luch
Journal:  Toxicol Res (Camb)       Date:  2019-11-19       Impact factor: 3.524

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.